Published on in Vol 8, No 4 (2020): April

Preprints (earlier versions) of this paper are available at, first published .
Use of a Smartphone-Based Mobile App for Weight Management in Obese Minority Stroke Survivors: Pilot Randomized Controlled Trial With Open Blinded End Point

Use of a Smartphone-Based Mobile App for Weight Management in Obese Minority Stroke Survivors: Pilot Randomized Controlled Trial With Open Blinded End Point

Use of a Smartphone-Based Mobile App for Weight Management in Obese Minority Stroke Survivors: Pilot Randomized Controlled Trial With Open Blinded End Point

Original Paper

1Department of Physical Medicine and Rehabilitation, University of Texas Southwestern Medical Center, Dallas, TX, United States

2Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX, United States

3Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX, United States

4College of Optometry, University of Houston, Houston, TX, United States

5Division of Clinical and Translational Sciences, Department of Internal Medicine, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, United States

6Institute for Stroke and Cerebrovascular Disease, University of Texas Health Science Center at Houston, Houston, TX, United States

7Department of Neurology, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX, United States

8Clinical Innovation and Research Institute, Memorial Hermann Hospital – Texas Medical Center, Houston, TX, United States

Corresponding Author:

Nneka L Ifejika, MPH, MD

Department of Physical Medicine and Rehabilitation

University of Texas Southwestern Medical Center

5323 Harry Hines Blvd

Dallas, TX

United States

Phone: 1 2146488762


Background: Minorities have an increased incidence of early-onset, obesity-related cerebrovascular disease. Unfortunately, effective weight management in this vulnerable population has significant barriers.

Objective: Our objective was to determine the feasibility and preliminary treatment effects of a smartphone-based weight loss intervention versus food journals to monitor dietary patterns in minority stroke patients.

Methods: Swipe out Stroke was a pilot prospective randomized controlled trial with open blinded end point. Minority stroke patients and their caregivers were screened for participation using cluster enrollment. We used adaptive randomization for assignment to a behavior intervention with (1) smartphone-based self-monitoring or (2) food journal self-monitoring. The smartphone group used Lose it! to record meals and communicate with us. Reminder messages (first 30 days), weekly summaries plus reminder messages on missed days (days 31-90), and weekly summaries only (days 91-180) were sent via push notifications. The food journal group used paper diaries. Both groups received 4 in-person visits (baseline and 30, 90, and 180 days), culturally competent counseling, and educational materials. The primary outcome was reduced total body weight.

Results: We enrolled 36 stroke patients (n=23, 64% African American; n=13, 36% Hispanic), 17 in the smartphone group, and 19 in the food journal group. Mean age was 54 (SD 9) years; mean body mass index was 35.7 (SD 5.7) kg/m2; education, employment status, and family history of stroke or obesity did not differ between the groups. Baseline rates of depression (Patient Health Questionnaire-9 [PHQ-9] score median 5.5, IQR 3.0-9.5), cognitive impairment (Montreal Cognitive Assessment score median 23.5, IQR 21-26), and inability to ambulate (5/36, 14% with modified Rankin Scale score 3) were similar. In total, 25 (69%) stroke survivors completed Swipe out Stroke (13/17 in the smartphone group, 12/19 in the food journal group); 1 participant in the smartphone group died. Median weight change at 180 days was 5.7 lb (IQR –2.4 to 8.0) in the smartphone group versus 6.4 lb (IQR –2.2 to 12.5; P=.77) in the food journal group. Depression was significantly lower at 30 days in the smartphone group than in the food journal group (PHQ-9 score 2 vs 8; P=.03). Clinically relevant depression rates remained in the zero to minimal range for the smartphone group compared with mild to moderate range in the food journal group at day 90 (PHQ-9 score 3.5 vs 4.5; P=.39) and day 180 (PHQ-9 score 3 vs 6; P=.12).

Conclusions: In a population of obese minority stroke survivors, the use of a smartphone did not lead to a significant difference in weight change compared with keeping a food journal. The presence of baseline depression (19/36, 53%) was a confounding variable, which improved with app engagement. Future studies that include treatment of poststroke depression may positively influence intervention efficacy.

Trial Registration: NCT02531074;

JMIR Mhealth Uhealth 2020;8(4):e17816



Importance of the Problem

Decades of research have shown a disproportionate incidence of obesity among African American and Hispanic populations in the United States [1-3]. Minorities have a median age at first stroke, which is highly correlated with obesity, 10 to 13 years earlier than non-Hispanic whites [4,5]. The early onset of stroke in minorities is expensive. Direct medical costs for African American stroke patients are estimated to top US $16 billion in 2020; by 2030, stroke prevalence is expected to rise the most among Hispanic men, with direct costs of care increasing over 300% since 2012 [6].

Adherence to evidence-based therapies for obesity management in minority stroke patients is insufficient. Previous studies have demonstrated success through restrictive health promotion interventions [7] and stroke navigators [8], both of which require close follow-up by a medical professional. Unfortunately, inadequate finances and lack of health insurance are barriers to care in minorities [9]; therefore, study protocols that require frequent medical follow-up are not generalizable.

Prior Work

The efficacy of smartphone-based self-monitoring to facilitate weight loss is well established. Wang et al [10] conducted a randomized controlled trial in a largely African American population, comparing a smartphone-based behavioral intervention for weight loss and glycemic control versus paper diaries or usual care. The smartphone group experienced a 2.73% weight loss at 6 months, compared with 0.13% weight loss in the paper diary group and a 0.49% weight gain in the usual-care group [10]. Minority populations are willing adopters of mobile health (mHealth) technology; a recent analysis by Asan et al of the Health Information National Trends Survey of American adults found that minorities were less likely to indicate they had no interest in exchanging health tips electronically with a health care provider [11].

However, there may be an attenuated effect of electronic device use in patients with chronic diseases, such as stroke. A study by Robbins et al showed that those with self-reported “very good or excellent” health or those who engaged in physical activity were more likely to download a health app [12]. Furthermore, in mHealth studies involving high-need, high-cost populations, Singh et al found that only 30.3% of the apps were identifiable and available to the public [13]. As stroke is a chronic end-organ disease with a high incidence of physical impairments, stroke survivors may have lower use of electronic interventions.


The Swipe out Stroke study tested the feasibility and preliminary treatment effects of using a readily available smartphone-based weight loss intervention in obese minority stroke patients versus food journals. Stroke affects the cognitive domains of attention, memory, language, and orientation [14]; approximately 30% of stroke patients develop dementia within 1 year [15]. These cognitive challenges may lead to limited mHealth research in the minority stroke population, which is increasing in volume and health care costs. We hypothesized that personal engagement with health care professionals through the mobile app would provide positive reinforcement and give support when participants experienced difficulty with program maintenance.

Study Design

Swipe out Stroke was a phase 1, pilot, prospective, randomized controlled trial with open blinded end point study. The blinded end point committee consisted of the senior authors (JG, SS) and the statistician (CC). We evaluated 2 groups—(1) a group receiving a behavior intervention with smartphone-based self-monitoring and (2) a group receiving a behavior intervention with food journal self-monitoring—for differences in weight loss at day 30, day 90, and day 180 of the study period. We used a mixed-methods design with quantitative measures. We distributed exit surveys to determine participants’ acceptance of the intervention; we report the quantitative results in this paper.


This study was approved by the Institutional Review Board at the McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, Texas, USA (HSC-MS-13-0608). We obtained informed consent from both study participants and their caregivers, detailing the purpose of the study, frequency of visits, descriptors of the smartphone and food journal interventions, benefits, risks, protection of privacy, and study withdrawal procedures. The Consolidated Standards of Reporting Trials of Electronic and Mobile Health Applications and Online Telehealth (CONSORT-EHEALTH) checklist served as a guide for reporting this study (Multimedia Appendix 1 [16]). The trial is registered with (NCT02531074).

Patient Population and Setting

We screened obese African American or Hispanic patients age 18 years and older, acutely hospitalized for ischemic or hemorrhagic stroke. Textbox 1 outlines the inclusion and exclusion criteria. The setting was a Joint Commission–accredited Comprehensive Stroke Center in Houston, Texas, USA with a 322-km telemedicine radius, reaching areas with a large underinsured population. The Joint Commission is a US nonprofit organization that accredits more than 22,000 US health care organizations and programs. Joint Commission accreditation is recognized by the majority of US state governments as a condition of licensure for receiving Medicare and Medicaid reimbursements.

Swipe out Stroke inclusion and exclusion criteria.

Inclusion criteria

  • Ischemic or hemorrhagic stroke.
  • Age 18-85 years.
  • African American or Hispanic ethnicity.
  • Poststroke modified Rankin Scale (mRS) score 0-3.
  • Poststroke body mass index >30 kg/m2.
  • Prescription medication for diabetes mellitus, hypertension or hyperlipidemia.
  • Willing to follow a healthy eating pattern and NOT use weight loss medications.
  • Personal or caregiver ownership of a computer, smartphone or other smart device (iPhone or Android platform) with internet access.
  • If patient has alexia, agraphia, acalculia, dementia or blindness, caregiver must be willing to complete the intervention.

Exclusion criteria

  • Preexisting disability with mRS score ≥4.
  • Contraindications to weight loss (planning to become pregnant, history of an eating disorder).
  • Steroid use for suspected vasculitis.
  • Current or recent (past 6 months) participation in a weight loss program or use of weight loss medication.
Textbox 1. Swipe out Stroke inclusion and exclusion criteria.

Sample Size Estimate

We aimed to recruit 50 patients in Swipe out Stroke, with retention of 15 patients in each group (n=30). Based on clinical estimates, we anticipated a 50% completion rate in the smartphone group and a 10% completion rate in the food journal group. Due to several large regional flooding events during the study period (March 2015 to December 2016), we closed enrollment upon achieving 17 patients in the smartphone group and 19 patients in the food journal group (n=36). Completion rates in both groups were higher than clinical estimates.


We randomly assigned stroke survivors to either the smartphone group or food journal group in a 1 to 1 ratio, using an adaptive covariate randomization algorithm. The adaptive randomization schema used the Pearson chi-square statistic to measure treatment imbalances in stroke severity (modified Rankin Scale score of 0-1: no symptoms to no significant disability; or modified Rankin Scale score of 2-3: slight to moderate disability), age, and sex. We determined the presence of depression at randomization using the Patient Health Questionnaire-9 (PHQ-9) survey; we equally allocated participants with depression to the smartphone and food journal groups in 3 categories: zero to minimal (score 0-4), mild to moderate (5-14), and moderately severe to severe (>14). We recalculated treatment assignment probability for each new patient; random assignment using a Web-based management app achieved the best balance between the smartphone and food journal groups. Caregivers joined the group of the study participant to facilitate participation in the protocol and compliance with the study intervention.



Participants were screened by the stroke social worker and a member of the Swipe out Stroke research team during the acute hospitalization. After informed consent was obtained, the baseline clinic visit occurred within 2 weeks of hospital discharge.

Smartphone Group

During the baseline visit, a member of the study team created a user account for the mobile app (Lose It! version 5.2.1; FitNow, Inc, Boston, MA, USA) by using the participant’s email address. Each participant and caregiver (if applicable) received a tutorial on how to download and use Lose It! on his or her personally owned smartphone. Lose It! is a free mobile app.

For each participant, we implemented a 10% weight loss goal and provided a value for maximum daily caloric intake under the Budget column (Figure 1). Participants could search for foods, including restaurant items, or scan the bar codes of grocery items, with direct upload onto the Lose It! platform. Nutritional data were uploaded from food labels of grocery items as mandated by the US Food and Drug Administration since 1994, and from restaurants as mandated by each state. The number of calories consumed could be increased with physical activity and logged in the Exercise column, which varied based on exercise duration and intensity. The net calories each day equaled the total of food calories minus exercise calories (Figure 1).

Figure 1. Example of a smartphone group Lose it! weight loss app screenshot.
View this figure

During the initiation phase (baseline to day 30), we created a pattern of compliance. Participants received daily monitoring of caloric intake, with reminder messages via push notifications. During the application phase (day 31-90), weekly push notification summaries of compliance were sent, with reminder messages on missed days. The maintenance phase (days 91-180) consisted of weekly summaries with no reminder messages. Details of the smartphone intervention protocol and message examples have been published [17].

Food Journal Group

Similar to the smartphone group, for the food journal group we calculated a goal of 10% body weight reduction during the baseline visit. We used the pocket-sized CalorieKing Food & Exercise Journal [18]; each journal contained space to document 10 weeks of food intake; a weekly summary page; areas to record calories, fat, protein, and carbohydrate; and a 4-page mini-calorie, fat, and carbohydrate counter to reference beverages, meats, fruits, vegetables, cereals, snack foods, and popular fast food establishments.

Interventions for Both Groups

Participants in both groups received culturally competent dietary counseling by a clinician of their ethnic group, measuring cups, the US Department of Health and Human Services Dietary Approaches to Stop Hypertension eating plan guide, American Heart Association (AHA) cookbooks, and AHA reading materials (Suggested Servings from Each Food Group, Choosing a Restaurant, Dining Out Tips by Cuisine, and Ordering your Meal). At the end of each phase, both groups returned to the clinic for weight measurements and counseling. Study visits were at no cost to participants and caregivers.

Feasibility and Treatment Fidelity

We measured study feasibility using retention rates at day 180 and adherence to the self-monitoring intervention at days 30, 90, and 180. We measured adherence to the smartphone intervention through a coaching tool integrated with the Lose It! platform (Ascend for Lose It!). Smartphone participants, with caregiver assistance if needed, were instructed to enter food daily, though either the functionality of the mobile app or free text. We measured adherence to the food journal intervention through review of written entries, with similar caregiver assistance.


Demographics and Self-Reported Cerebrovascular Risk Factors

We collected data on participants’ age, sex, ethnicity, marital status, employment status, educational level, weight and height (to calculate body mass index), and stroke-related disability level in a sociodemographic questionnaire. We assessed cognitive impairments using the Montreal Cognitive Assessment (MoCA); a score of 26 and higher was considered normal [19]. We collected personal health, family history, and past medical history information using a general health history form.

Objective Cerebrovascular Risk Factors

We collected cerebrovascular risk factors in both groups, with normative ranges derived from AHA guidelines [20,21]. Baseline study measurements were collected within 2 weeks of the index stroke.

Primary Outcome

The primary outcome was a reduction in total body weight. The United States Preventive Services Task Force guidelines indicate that a weight reduction of 5% to 10% yields measurable improvement in risk factors for cerebrovascular disease [22]. We measured overall weight reduction in both the smartphone and food journal groups.

We planned a subgroup analysis of weight loss in depression screen–positive and depression screen–negative participants a priori. Poststroke depression is one of the most frequent neuropsychiatric consequences of stroke, affecting approximately 30% of stroke survivors [23]. The presence of poststroke depression has been linked to reduced participation in structured rehabilitation programs [24,25]. Swipe out Stroke was a type of structured dietary rehabilitation intervention; therefore, we analyzed the combined group (smartphone and food journal).

Secondary Outcomes

Secondary outcomes included compliance with the weight loss intervention, improvement in depression, and, if abnormal, normalization of systolic blood pressure, serum low-density lipoprotein value, proportion of total hemoglobin, and proportion of serum coagulation factor VIII.

Data Management

Paper case report forms (screening, feasibility, and tracking forms) were collected and stored in the Institute for Stroke and Cerebrovascular Disease Research Coordinator office at the McGovern Medical School at University of Texas Health Science Center at Houston. We used REDCap version 6.10 (REDCap Consortium) for online form design, data entry, data verification, and data management. All forms were precoded to minimize errors. During data collection, forms were screened upon receipt for completeness.

Statistical Analysis

We reported descriptive statistics (frequency and percentage for categorical variables, and mean and standard deviation or median and IQR for continuous variables). We used 2-sample t test or Wilcoxon rank sum test to compare continuous variables, and Fisher exact test to compare categorical variables.

We obtained demographics and cerebrovascular risk factors by self-report. Cognitive testing was completed at baseline. Depression screening was completed at baseline and days 30, 90, and 180 and compared between the smartphone and food journal groups using Wilcoxon rank sum test. We measured the primary outcome as weight change in pounds; we also compared weight change by the presence of depression (defined as self-reported depression or PHQ-9 score ≥5). We performed all analyses using SAS version 9.4 (SAS Institute); we considered P<.05 to be significant.

Study Period

Participants were enrolled in Swipe out Stroke between March 2015 and May 2016. The final follow-up visit occurred in December 2016. There were no significant changes in computer hardware or internet delivery resources during the study period. The duration of each in-person study visit was 30 minutes. For the smartphone group, engagement by a member of the study team took approximately 3 minutes per participant during the initiation phase, 2 minutes per participant during the application phase, and 1 minute per participant during the maintenance phase.

Feasibility and Treatment Fidelity

The CONSORT flow diagram in Figure 2 details Swipe out Stroke participant retention. A total of 25 (69%) stroke survivors completed Swipe out Stroke (13/17 in the smartphone group, 12/19 in the food journal group); 1 participant died in the smartphone group. The overall retention rate was 78% (28/36) at day 30, 72% (26/36) at day 90, and 69% (25/36) at day 180.

Figure 2. Swipe out Stroke Consolidated Standards of Reporting Trials (CONSORT) flow diagram.
View this figure

Intervention adherence was significantly higher at day 90 in the smartphone group than in the food journal group (10/17, 59% vs 4/19, 21%; P=.04). In the smartphone group, adherence to 1 self-monitored diet entry per day was 59% (10/17) at day 30 and 35% (6/17) at day 180. Adherence to 1 self-monitored diet entry per day in the food journal group was 42% (8/19) at day 30 and 11% (2/19) at day 180.

Demographics and Self-Reported Cerebrovascular Risk Factors

Table 1 describes participant demographics and self-reported cerebrovascular risk factors by treatment group. Equal allocation was achieved between the smartphone and food journal groups. The mean participant age was 54 years, and mean education level was completion of 12th grade, some College, or General Education Development. Of the 36 participants, 20 (56%) were male and 23 (64%) were African American. The majority of participants had a source of income, either through retirement or disability (14/36) or employment (self or significant other, 20/36). The participants’ overall median PHQ-9 scores (5.5) signified mild to moderate depression; the median MoCA score (23.5, IQR 21-26) indicated mild cognitive impairment.

Table 1. Demographics and self-reported cerebrovascular risk factors.
CharacteristicsTotal (n=36)Smartphone (n=17)Food journal (n=19)P value
Age (years), mean (SD)54.1 (9.4)54.4 (10.9)53.8 (8.2).87a
Race, n (%)

Black23 (64)9 (53)14 (74).30b

Hispanic13 (36)8 (47)5 (26)
Male sex, n (%)20 (56)9 (53)11 (58).77c
Marital status, n (%)

Married or domestic partner21 (58)10 (59)11 (58).96c

Not married15 (42)7 (41)8 (42)
Employment status, n (%)

Employed20 (56)10 (59)10 (53).87b

Not employed2 (6)1 (6)1 (5)

Retired or receiving disability14 (39)6 (35)8 (42)
Education, n (%)

Master’s degree5 (14)1 (6)1 (5).26b

Bachelor’s degree3 (8)0 (0)3 (16)

Associate’s degree or other21 (58)4 (24)1 (5)

High school, some college, or GEDd5 (14)9 (53)12 (63)

Less than high school2 (6)3 (18)2 (11)
Modified Rankin Scale score, n (%)

04 (11)2 (12)2 (11).92b

119 (53)9 (53)10 (53)

28 (22)3 (18)5 (26)

35 (14)3 (18)2 (11)
Patient Health Questionnaire-9, median (IQR)5.5 (3.0-9.5)6 (2-10)5 (3-9).74e
Patient Health Questionnaire-9, n (%)


0-417 (48)8 (47)9 (47)

5-1414 (39)6 (35)8 (42)

≥155 (14)3 (18)2 (11)
Self-reported depression or psychiatric disease, n (%)12 (33)5 (29)7 (37).73b
Montreal Cognitive Assessment, median (IQR)23.5 (21-26)23 (19-25)25 (21-27).15e
Medical history, n (%)

Cardiac disease11 (31)4 (24)7 (37).48b

Hypertension35 (97)17 (100)18 (95)>.99b

Hyperlipidemia21 (60)10 (63)11 (58).78c

Family history of obesity33 (94)16 (94)17 (94)>.99b

Family history of stroke24 (69)12 (71)12 (67)>.99b

Personal history of stroke7 (20)3 (19)4 (21)>.99b

aP values obtained by 2-sample t test.

bP values obtained by Fisher exact test.

cP values obtained by chi-square test.

dGED: General Education Development.

eP values obtained by Wilcoxon rank sum test.

Objective Cerebrovascular Risk Factors

Table 2 describes objective cerebrovascular risk factors. The mean baseline body mass index was 35.7 (SD 5.7) kg/m2, systolic blood pressure was 127.7 (SD 17.0) mm Hg, and serum total cholesterol, high-density lipoprotein, low-density lipoprotein, and triglycerides were in the reference ranges. Median proportion of total hemoglobin (0.061, IQR 0.056-0.07) and proportion of factor VIII (2.29, IQR 1.63-3.09) were both elevated.

Table 2. Objective cerebrovascular risk factors.
Risk factorsTotal (n=36)Smartphone (n=17)Food journal (n=19)P value
Body mass index (kg/m2), mean (SD)35.7 (5.7)35.1 (5.3)36.2 (6.2).57a
Weight (lb), mean (SD)228.3 (47.1)219.9 (49.6)235.8 (44.7).32a
Systolic blood pressure (mmHg), mean (SD)127.7 (17.0)125.1 (9.8)130.1 (14.1).38a
Total cholesterol (mmol/L), median (IQR)9.27 (7.77-10.38)8.94 (7.21-10.16)9.43 (7.88-10.43).51b
Low-density lipoprotein (mmol/L), median (IQR)4.88 (4.05-6.47)4.94 (3.94-6.16)4.77 (4.16-6.55).81b
High-density lipoprotein (mmol/L), median (IQR)2.44 (2.0-2.66)2.44 (2.05-2.66)2.44 (1.94-2.55).51b
Triglycerides (mmol/L), median (IQR)7.83 (5.55-9.63)7.05 (4.5-9.55)7.88 (5.83-11.77).40b
Proportion of total hemoglobin, median (IQR)0.061 (0.056-0.07)0.062 (0.056-0.096)0.06 (0.056-0.065).39b
Proportion of factor VIII, median (IQR)2.29 (1.63-3.09)2.64 (1.68-3.70)2.15 (1.44-3.04).26b

aP values by 2-sample t test.

bP values by Wilcoxon rank sum test.

Primary Outcome

Figure 3 summarizes descriptive findings on weight outcomes at each study collection time point. There were no statistically significant differences in weight loss between the smartphone and food journal groups. At day 180, the smartphone group had a median weight loss of 5.7 pounds (IQR –2.4 to 8.0), and the food journal group had a median weight loss of 6.4 pounds (IQR –2.2 to 12.5; P=.77). There was a 2.1% median weight change in the smartphone group, compared with a 2.9% median weight change in the food journal group (P=.63). In the combined smartphone and food journal analysis at day 180, the depression screen–positive group lost 3.9 pounds (IQR –10.1 to 14), and the depression screen–negative group lost 6.4 pounds (IQR –2.4 to 15; P=.49).

Secondary Outcomes

There was no difference in the proportion of total hemoglobin above 0.06 and proportion of factor VIII above 2 in the smartphone and food journal groups at 180 days (P=.68).

Depression was significantly lower at 30 days in the smartphone group than in the food journal group (PHQ-9 score 2 vs 8; P=.03) (Figure 4). Clinically relevant depression rates remained in the zero to minimal range for the smartphone group compared with the mild to moderate range in the food journal group at day 90 (PHQ-9 score 3.5 vs 4.5; P=.39) and day 180 (PHQ-9 score 3 vs 6; P=.12) (Figure 4). The IQR for PHQ-9 scores remained lower in the smartphone group than in the food journal group at day 30 (smartphone group IQR 1-4 vs food journal group IQR 4-10.5), day 90 (IQR 1-8 vs IQR 3-10), and day 180 (IQR 0-6 vs IQR 1-9).

Figure 3. Median weight change by intervention group and depression status.
View this figure
Figure 4. Depression by median Patient Health Questionnaire-9 (PHQ-9) score in the smartphone and food journal groups. Green arrow Indicates zero to minimal depression cutoff (PHQ-9 ≤4). *Statistically significant difference (P=.03).
View this figure

Principal Findings

The use of our smartphone-based intervention did not lead to a significant difference in weight change compared with the use of a food journal–based intervention. To our knowledge, this study is the first to implement a self-monitored smartphone-based intervention, with caregiver support, in minority patients with poststroke cognitive impairments. The time interval immediately following an acute stroke presents the opportunity to successfully change dietary patterns in patients and their caregivers, who influence the availability of healthy food choices. The overall retention rates establish an early precedent in this population at increased risk for recurrent stroke. A recent meta-analysis by Lui et al yielded no original clinical trials of the role of mHealth in recurrent stroke prevention [26].

The findings of increased patient engagement and adherence to self-monitoring in the smartphone group are consistent with studies in non–stroke populations [27-31]. Augmenting electronic health tools with non-Web–based components, such as culturally competent dietary counseling, measuring cups, and AHA cookbooks and reading materials, was well received by both the smartphone and food journal groups. Exit interviews reflected appreciation of a template that can be followed to establish healthy eating behaviors. The provision of this heightened supportive care, plus the Hawthorne effect, could have resulted in no significant difference in weight loss between the food journal and smartphone groups.

We found significantly decreased depression rates in the smartphone group at 30 days, which remained in the zero to minimal range; the food journal group had PHQ-9 scores indicative of mild to moderate depression throughout the study. Although both groups had built-in caregiver support, the smartphone group received reminder messages and positive reinforcement on a daily, then weekly, basis, providing support for the weight loss intervention. The use of the Lose It! mobile app as a tool for mitigation of poststroke depression is an interesting, cost-free adjunct in an underresourced minority population. Qu et al found that the top-rated mobile apps for depression were available at a direct cost for more advanced features (up to US $29.99 per month) or an indirect cost in terms of advertisements, which raised privacy concerns [32]. During the first 6 months after a stroke, depression appears to be reactive and is correlated with increased severity of impairment in activities of daily living at 1 year [33]. Kim et al described an improvement in depression at 12 weeks using a smartphone-based mHealth system in a Korean cohort [34]. The effect of direct patient engagement via existing mobile apps, on both poststroke depression and weight loss, is an exciting direction of future studies.


There are several limitations to this study. First, the primary focus was feasibility and early treatment effect; there was not sufficient power to detect group differences. Second, study participants used their personally owned smartphones; during exit interviews, several participants noted financial limitations. The adherence to self-monitoring might have been different if smartphones with data plans had been provided. Third, study participation might have been increased within the smartphone group due to lower rates of depression. We did not examine interactions of cognitive impairment or depression with the treatment effect of each intervention, due to the small sample size in this pilot study. Fourth, our study evaluated short-term outcomes; assessment of the long-term effects of a smartphone-based intervention on weight loss and poststroke depression is a goal for future studies.


Swipe out Stroke provided useful data on designing subsequent weight management trials for obese minority stroke survivors. Both the smartphone and the food journal interventions resulted in weight loss. Data from Swipe out Stroke suggest that poststroke depression improves with smartphone-based engagement. Future minority research studies that include treatment of poststroke depression and cognitive rehabilitation may positively influence intervention efficacy.


NLI has received a University of Texas Southwestern Medical Center and Texas Health Resources Clinical Scholar Award (#4). NLI’s and CCC’s previous work at the Center for Clinical and Translational Sciences at the McGovern Medical School at University of Texas Health Science Center at Houston was funded by US National Institutes of Health (NIH)/National Center for Advancing Translational Sciences Clinical and Translational Award UL1 TR000371 and KL2 TR000370. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the NIH. NLI received the NIH/National Institute of Neurological Disorders and Stroke Diversity Supplement to P50 NS 044227, the University of Texas Specialized Program of Translational Research in Acute Stroke.

Authors' Contributions

NLI conceived the study concept and design. CCC, SIS, and JCG analyzed and interpreted the data. CCC conducted all statistical analyses. NLI, MB, EAN, CCC, SIS, and JCG critically revised the manuscript for important intellectual content. SIS and JCG provided administrative, technical, or material support.

Conflicts of Interest

None declared.

Multimedia Appendix 1

CONSORT-eHEALTH checklist (V 1.6.1).

PDF File (Adobe PDF File), 1482 KB

  1. National Institutes of Health, National Heart, Lung, and Blood Institute. Obesity Education Initiative: Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: The Evidence Report. NIH Publication No 98-4083. Washington, DC: U.S. Department of Health and Human Services; 1998 Sep.   URL: [accessed 2019-09-12]
  2. Sacco RL, Boden-Albala B, Gan R, Chen X, Kargman DE, Shea S, et al. Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol 1998 Feb 01;147(3):259-268. [CrossRef] [Medline]
  3. National Center for Health Statistics. Health, United States, 2016: With Chartbook on Long-Term Trends in Health. Hyattsville, MD: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2017.   URL: [accessed 2019-11-07]
  4. Christian JB, Lapane KL, Toppa RS. Racial disparities in receipt of secondary stroke prevention agents among US nursing home residents. Stroke 2003 Nov;34(11):2693-2697. [CrossRef] [Medline]
  5. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2017 update: a report from the American Heart Association. Circulation 2017 Mar 07;135(10):e146-e603. [CrossRef] [Medline]
  6. Ovbiagele B, Goldstein LB, Higashida RT, Howard VJ, Johnston SC, Khavjou OA, American Heart Association Advocacy Coordinating Committee and Stroke Council. Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke 2013 Aug;44(8):2361-2375 [FREE Full text] [CrossRef] [Medline]
  7. Rimmer JH, Braunschweig C, Silverman K, Riley B, Creviston T, Nicola T. Effects of a short-term health promotion intervention for a predominantly African-American group of stroke survivors. Am J Prev Med 2000 May;18(4):332-338. [CrossRef] [Medline]
  8. Ovbiagele B, Saver JL, Fredieu A, Suzuki S, McNair N, Dandekar A, et al. PROTECT: a coordinated stroke treatment program to prevent recurrent thromboembolic events. Neurology 2004 Oct 12;63(7):1217-1222. [CrossRef] [Medline]
  9. Pratt CA, Ha L, Levine SR, Pratt CB. Stroke knowledge and barriers to stroke prevention among African Americans: implications for health communication. J Health Commun 2003;8(4):369-381. [CrossRef] [Medline]
  10. Wang J, Cai C, Padhye N, Orlander P, Zare M. A behavioral lifestyle intervention enhanced with multiple-behavior self-monitoring using mobile and connected tools for underserved individuals with type 2 diabetes and comorbid overweight or obesity: pilot comparative effectiveness trial. JMIR Mhealth Uhealth 2018 Apr 10;6(4):e92 [FREE Full text] [CrossRef] [Medline]
  11. Asan O, Cooper Ii F, Nagavally S, Walker RJ, Williams JS, Ozieh MN, et al. Preferences for health information technologies among US adults: analysis of the Health Information National Trends Survey. J Med Internet Res 2018 Oct 18;20(10):e277 [FREE Full text] [CrossRef] [Medline]
  12. Robbins R, Krebs P, Jagannathan R, Jean-Louis G, Duncan DT. Health app use among US mobile phone users: analysis of trends by chronic disease status. JMIR Mhealth Uhealth 2017 Dec 19;5(12):e197 [FREE Full text] [CrossRef] [Medline]
  13. Singh K, Drouin K, Newmark LP, Filkins M, Silvers E, Bain PA, et al. Patient-facing mobile apps to treat high-need, high-cost populations: a scoping review. JMIR Mhealth Uhealth 2016 Dec 19;4(4):e136 [FREE Full text] [CrossRef] [Medline]
  14. Cumming TB, Marshall RS, Lazar RM. Stroke, cognitive deficits, and rehabilitation: still an incomplete picture. Int J Stroke 2013 Jan;8(1):38-45. [CrossRef] [Medline]
  15. Al-Qazzaz NK, Ali SH, Ahmad SA, Islam S, Mohamad K. Cognitive impairment and memory dysfunction after a stroke diagnosis: a post-stroke memory assessment. Neuropsychiatr Dis Treat 2014;10:1677-1691 [FREE Full text] [CrossRef] [Medline]
  16. Eysenbach G, CONSORT-EHEALTH Group. CONSORT-EHEALTH: improving and standardizing evaluation reports of Web-based and mobile health interventions. J Med Internet Res 2011;13(4):e126 [FREE Full text] [CrossRef] [Medline]
  17. Ifejika NL, Noser EA, Grotta JC, Savitz SI. Swipe out Stroke: feasibility and efficacy of using a smart-phone based mobile application to improve compliance with weight loss in obese minority stroke patients and their carers. Int J Stroke 2016 Jul;11(5):593-603. [CrossRef] [Medline]
  18. Borushek A. The CalorieKing Food & Exercise Journal. Costa Mesa, CA: Family Health Publications; 2006.
  19. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005 Apr;53(4):695-699. [CrossRef] [Medline]
  20. Jellinger PS, Handelsman Y, Rosenblit PD, Bloomgarden ZT, Fonseca VA, Garber AJ, et al. American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for the management of dyslipidemia and prevention of cardiovascular disease. Endocr Pract 2017 Apr;23(Suppl 2):1-87. [CrossRef] [Medline]
  21. Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, Council on Quality of Care and Outcomes Research, and the American Diabetes Association. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2015 Aug 25;132(8):691-718. [CrossRef] [Medline]
  22. Leblanc ES, O'Connor E, Whitlock EP, Patnode CD, Kapka T. Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2011 Oct 04;155(7):434-447. [CrossRef] [Medline]
  23. Hackett ML, Pickles K. Part I: frequency of depression after stroke: an updated systematic review and meta-analysis of observational studies. Int J Stroke 2014 Dec;9(8):1017-1025. [CrossRef] [Medline]
  24. Paolucci S, Di Vita A, Massicci R, Traballesi M, Bureca I, Matano A, et al. Impact of participation on rehabilitation results: a multivariate study. Eur J Phys Rehabil Med 2012 Sep;48(3):455-466 [FREE Full text] [Medline]
  25. Subramanian SK, Chilingaryan G, Sveistrup H, Levin MF. Depressive symptoms influence use of feedback for motor learning and recovery in chronic stroke. Restor Neurol Neurosci 2015;33(5):727-740. [CrossRef] [Medline]
  26. Liu S, Feng W, Chhatbar PY, Liu Y, Ji X, Ovbiagele B. Mobile health as a viable strategy to enhance stroke risk factor control: a systematic review and meta-analysis. J Neurol Sci 2017 Jul 15;378:140-145 [FREE Full text] [CrossRef] [Medline]
  27. Burke LE, Swigart V, Warziski TM, Derro N, Ewing LJ. Experiences of self-monitoring: successes and struggles during treatment for weight loss. Qual Health Res 2009 Jun;19(6):815-828 [FREE Full text] [CrossRef] [Medline]
  28. Yon BA, Johnson RK, Harvey-Berino J, Gold BC, Howard AB. Personal digital assistants are comparable to traditional diaries for dietary self-monitoring during a weight loss program. J Behav Med 2007 Apr;30(2):165-175. [CrossRef] [Medline]
  29. Burke LE, Conroy MB, Sereika SM, Elci OU, Styn MA, Acharya SD, et al. The effect of electronic self-monitoring on weight loss and dietary intake: a randomized behavioral weight loss trial. Obesity (Silver Spring) 2011 Feb;19(2):338-344 [FREE Full text] [CrossRef] [Medline]
  30. Wang J, Sereika SM, Chasens ER, Ewing LJ, Matthews JT, Burke LE. Effect of adherence to self-monitoring of diet and physical activity on weight loss in a technology-supported behavioral intervention. Patient Prefer Adherence 2012;6:221-226 [FREE Full text] [CrossRef] [Medline]
  31. Turk MW, Elci OU, Wang J, Sereika SM, Ewing LJ, Acharya SD, et al. Self-monitoring as a mediator of weight loss in the SMART randomized clinical trial. Int J Behav Med 2013 Dec;20(4):556-561 [FREE Full text] [CrossRef] [Medline]
  32. Qu C, Sas C, Daudén Roquet C, Doherty G. Functionality of top-rated mobile apps for depression: systematic search and evaluation. JMIR Ment Health 2020 Jan 24;7(1):e15321 [FREE Full text] [CrossRef] [Medline]
  33. Robinson RG. The Clinical Neuropsychiatry of Stroke: Cognitive, Behavioral and Emotional Disorders Following Vascular Brain Injury. 2nd edition. Cambridge, MA: Cambridge University Press; 2006.
  34. Kim DY, Kwon H, Nam K, Lee Y, Kwon H, Chung YS. Remote management of post stroke patients with a smartphone-based management system integrated in clinical care: prospective, nonrandomized, interventional study. J Med Internet Res 2020 Feb 27;22(2):e15377 [FREE Full text] [CrossRef] [Medline]

AHA: American Heart Association
CONSORT-EHEALTH: Consolidated Standards of Reporting Trials of Electronic and Mobile Health Applications and Online Telehealth
mHealth: mobile health
MoCA: Montreal Cognitive Assessment
PHQ-9: Patient Health Questionnaire-9

Edited by G Eysenbach; submitted 14.01.20; peer-reviewed by C Simons, R Ciptaningtyas, H Jin; comments to author 10.02.20; revised version received 05.03.20; accepted 23.03.20; published 22.04.20


©Nneka L Ifejika, Minal Bhadane, Chunyan C Cai, Elizabeth A Noser, James C Grotta, Sean I Savitz. Originally published in JMIR mHealth and uHealth (, 22.04.2020.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mHealth and uHealth, is properly cited. The complete bibliographic information, a link to the original publication on, as well as this copyright and license information must be included.